Admission Date:  [**2104-8-29**]       Discharge Date:  [**2104-9-11**]  Date of Birth:   [**2104-8-29**]       Sex:  M  Service:  NEONATOLOGY  [**Known lastname **] [**Known lastname 12056**]-[**Known lastname 51321**], triplet number two, was born at 34 weeks gestation by cesarean section, for a triplet gestation and preterm labor.
Mother is a 39-year-old G4, para 1, now 4, woman with previous obstetrical history remarkable for spontaneous abortion in [**2100**] and [**2102**], a 38 week spontaneous vaginal delivery in [**2097**], whose name is [**Name (NI) 6644**].
This pregnancy was complicated by preterm contractions leading to admission one week prior to delivery with tocolysis and betamethasone given at that time.
The elective cesarean section was performed without the progression of labor.
He has never required any supplemental oxygen and he has never had any apnea of prematurity.
Fluids, Electrolytes and Nutrition status:  Enteral feeds were begun on the day of delivery and were advanced without difficulty to full volume feeding and calorie enhanced formula or breast milk of 24 calories per ounce.
Gastrointestinal status:  The infant was treated with phototherapy for hyperbilirubinemia of prematurity on day of life three until day of life number five.
Hematology status:  The infant has received no blood product transfusions during his Neonatal Intensive Care Unit stay.
He is receiving supplemental iron of 2 mg/kg/day of elemental iron.
Infectious Disease status:  The infant never required evaluation for sepsis and never received any antibiotics during his Neonatal Intensive Care Unit stay.
Medications:  Iron sulfate (25 mg/mL 0.15 cc p.o.
Synagis RSV prophylaxis should be considered from [**Month (only) 359**] through [**Month (only) 547**] for infants who meet any of the following three criteria:  (1) Born at less than 32 weeks; (2) Born at 32 to 35 weeks and plan for day care during RSV season, with smoker in the household or with preschool sibs or (3) With chronic lung disease.
Influenza immunization should be considered annually in the fall for preterm infants with chronic lung disease once they reach six months of age.
Before this age the family and the care givers should be considered for immunization against influenza to protect the infant.
